|
Compellis Pharmaceuticals |
|
|
141 PowderHouse Blvd. Suite 1 Boston, MA 02144 USA phone:617-957-9858 fax:617-625-4132
|
| Symbol |
private |
| Founded |
0 |
| Employees |
|
|
|
| www.compellis.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Biopharmaceutical company
|
 |
| Management |
| Chris Adams, President and CEO
|
|
|
| |
| Keywords |
| obesity, diabetes, hypertension
|
|
|
|
|
|
| Description |
|
Biopharmaceutical company developing novel mechanism-based therapeutics for the treatment of obesity.
|
 |
| Products / Services |
|
 |
| Technology / Differentiation |
|
|
 |
| Market / Customers |
|
 |
| Competitors / Substitutes / Alternatives |
|
 |
| Strategy |
|
 |
| Funding |
|
|
 |
| Status |
|
|
 |
|
|
| |
|
|
|
|